AFP Stock Chart & Stats
AU$3.19
-AU$0.03(-1.16%)
At close: 4:00 PM EST
AU$3.19
-AU$0.03(-1.16%)
Day’s Range― - ―
52-Week RangeAU$2.20 - AU$3.38
Previous CloseN/A
Volume204.00
Average Volume (3M)2.52K
Market Cap
AU$342.68M
Enterprise ValueAU$442.36M
Total Cash (Recent Filing)AU$10.24M
Total Debt (Recent Filing)AU$54.11M
Price to Earnings (P/E)27.9
Beta0.25
Next Earnings
Nov 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.54%
Share Statistics
EPS (TTM)0.14
Shares Outstanding104,874,660
10 Day Avg. Volume3,466
30 Day Avg. Volume2,523
Financial Highlights & Ratios
PEG Ratio0.88
Price to Book (P/B)3.19
Price to Sales (P/S)1.38
P/FCF Ratio-29.69
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.15
Revenue Forecast (FY)AU$248.67M
AFT Pharmaceuticals Ltd. News
AFP FAQ
What was AFT Pharmaceuticals Ltd.’s price range in the past 12 months?
AFT Pharmaceuticals Ltd. lowest share price was AU$2.20 and its highest was AU$3.38 in the past 12 months.
What is AFT Pharmaceuticals Ltd.’s market cap?
AFT Pharmaceuticals Ltd.’s market cap is AU$342.68M.
When is AFT Pharmaceuticals Ltd.’s upcoming earnings report date?
AFT Pharmaceuticals Ltd.’s upcoming earnings report date is Nov 19, 2026 which is in 128 days.
How were AFT Pharmaceuticals Ltd.’s earnings last quarter?
AFT Pharmaceuticals Ltd. released its earnings results on May 20, 2026. The company reported AU$0.089 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.089.
Is AFT Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts AFT Pharmaceuticals Ltd.’s price is currently Overvalued.
Does AFT Pharmaceuticals Ltd. pay dividends?
AFT Pharmaceuticals Ltd. pays a Annually dividend of AU$0.024 which represents an annual dividend yield of 0.54%. See more information on AFT Pharmaceuticals Ltd. dividends here
What is AFT Pharmaceuticals Ltd.’s EPS estimate?
AFT Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AFT Pharmaceuticals Ltd. have?
AFT Pharmaceuticals Ltd. has 104,874,660 shares outstanding.
What happened to AFT Pharmaceuticals Ltd.’s price movement after its last earnings report?
AFT Pharmaceuticals Ltd. reported an EPS of AU$0.089 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 6.662%.
Which hedge fund is a major shareholder of AFT Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in AU:AFP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AFT Pharmaceuticals Ltd.
AFT Pharmaceuticals, along with its subsidiaries, focuses on the creation and distribution of pharmaceutical products across New Zealand, Australia, Asia, and other global markets. Their extensive product range addresses a variety of health categories, including but not limited to allergy relief, cold and flu remedies, digestive health, eye care, first aid essentials, nail and oral care, pain management, skincare solutions, and nutritional supplements. This company was established in 1997 and its main office is located in Auckland, New Zealand.
AFP Stock 12 Month Forecast
Average Price Target
―Technical Analysis
EBOS Group Limited
―
Fisher & Paykel Healthcare Corporation Limited
―
Pacific Edge Limited
―
TruScreen Group Ltd.
―
Rua Bioscience Ltd.
―
Options Prices
Currently, No data available
---








